z-logo
open-access-imgOpen Access
CD4 T Cell Responses to a Variant Antigen of the Malaria ParasitePlasmodium falciparum,Erythrocyte Membrane Protein–1, in Individuals Living in Malaria‐Endemic Areas
Author(s) -
Catherine E. M. Allsopp,
Latifu A. Sanni,
Lieke Reubsaet,
Francis M. Ndungu,
Chris Newbold,
Tabitha Mwangi,
Kevin Marsh,
Jean Langhorne
Publication year - 2002
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1086/339521
Subject(s) - malaria , plasmodium falciparum , parasite hosting , biology , virology , antigen , erythrocyte membrane , plasmodium (life cycle) , immunology , genetics , membrane , world wide web , computer science
Plasmodium falciparum erythrocyte membrane protein-1 (PfEMP-1) is a variant antigen on the surface of malaria-infected red blood cells. Antibody responses to PfEMP-1 correlate with immunity, and, therefore, PfEMP-1 may be a good candidate for a malaria vaccine. However, the specificity of CD4 T cells required for a protective variant-specific antibody response is not known. We have measured the CD4 T cell response to 3 different regions that are relatively homologous among different PfEMP-1 variants. The response to the cysteine-rich interdomain region was unusual in that the majority of donors, whether malaria exposed or not, had positive CD4 T cell, interleukin-10, and interferon-gamma responses. The CD4 T cell response to the exon 2 and duffy binding-like domain proteins was significantly greater in malaria-exposed donors than in unexposed Europeans, which suggests that these regions contain peptides recognized by T cells, which thus may be useful as components of a vaccine.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom